In recent years, more and more studies have confirmed its upregulated expression in breast cancer, liver cancer, gastric cancer, lung cancer, etc., in which LOXL2 plays a pivotal role in TME by promoting tumor-associated fibrosis and tumor angiogenesis [16]. Here, LOXL2 is linked to neoplasm.